Aug 2026· Archives of Osteoporosis· Vol 21· 0 citations· 22 references
Medicine
TL;DR
In patients with stage 3 CKD and stable renal function, bone microarchitecture identified impaired BMD not fully detected by DXA, and over 1 year, only minimal changes in bone parameters were observed.
Abstract
In a 1-year longitudinal study of 34 patients with stage 3 CKD and stable bone turnover markers there was no deterioration of bony quality. However, HR-pQCT identified impaired bone density in 73.5% of cases at baseline, which was undetected by DXA. Findings suggest early skeletal involvement despite stable renal function. It has been postulated that chronic kidney disease (CKD) is associated with bone loss. However, prospective data are limited, and it remains unclear whether bone loss or microarchitecture chances occurs in the early stages of CKD with stable renal function. In this longitudinal cohort study, patients with stage 3 CKD underwent dual-energy X-ray absorptiometry (DXA) and high-resolution peripheral quantitative computed tomography (HR-pQCT), with reassessment after 1 year. Bone biomarkers, including alkaline phosphatase, intact parathyroid hormone (iPTH), intact fibroblast growth factor-23 (iFGF-23), total procollagen type 1 N-terminal propeptide (tP1NP), and β-isomerized C-terminal telopeptide of type I collagen -I (β-CTX-I) were also measured. Thirty-four patients were included (51 ± 3 years, 44% men). Bone turnover markers remained stable during follow-up. Osteopenia and/or osteoporosis at one or more sites was found in 45.5% of participants. Low bone mineral density (BMD), T-score < -1, was observed in 32.3% (lumbar spine), 29.4% (total hip), 14.7% (1/3 distal radius), and 26.5% (ultradistal radius). HR-pQCT revealed impaired BMD in at least one site (tibia or radius) in 73.5% of cases. Renal function remained stable during follow-up, with no significant changes in bone biomarkers. DXA showed a slight but significant decline in T-scores at the total hip and 1/3 distal radius, whereas HR-pQCT parameters remained unchanged. In patients with stage 3 CKD and stable renal function, bone microarchitecture identified impaired BMD not fully detected by DXA. Over 1 year, however, only minimal changes in bone parameters were observed.
Background Chronic kidney disease (CKD) is associated with increased fracture risk not fully explained by reduced bone mineral density. CKD–mineral and bone disorder (CKD-MBD), involving abnormalities in bone turnover, mineralization, and microarchitecture, contributes to skeletal fragility. However, the relationship b...
Sushil Sharma, P. Sujir, Pranav Rajasekharan et al.· SAGE Open Medicine· 0 citations
BACKGROUND
Chronic kidney disease (CKD) disrupts mineral and bone metabolism, increasing fracture risk. Exercise may improve physical performance and help preserve bone mineral density (BMD), but data on the relationship between BMD and bone turnover markers during long-term exercise in CKD are limited. We explored pot...
V. Petrauskiene, Matthias Hellberg, Philippa Svensson et al.· JN. Journal of Nephrology (M...· 0 citations
It is suggested that younger patients undergoing hemodialysis with elevated PTH and ALP levels may benefit from a more intensive approach to the management of hyperparathyroidism and older and more frail patients with relatively low PTH levels may be more likely to exhibit low bone volume and turnover and could potenti...
Eduardo J. Duque, Lauren S. Lowe, C. Carbonara et al.· Archives of Osteoporosis· 0 citations
Background: Bone disease remains a major long-term complication after kidney transplantation. However, the relationship between circulating bone turnover markers (BTMs) and densitometric skeletal parameters in kidney transplant recipients (KTRs) remains incompletely understood. Methods: This single-center, cross-sectio...
Nada Akad, Ș. Bîlha, G. Dodi et al.· Journal of Clinical Medicine· 0 citations
No routinely measured biomarker demonstrated clinical utility for identifying BMD trajectory in this cohort of Saudi dual-energy X-ray absorptiometry patients, suggesting future studies with explicit treatment tracking and repeated bone-turnover measurements are required for confirmation.
L. Jambi, S. Kabrah· Journal of Clinical Medicine· 0 citations
BACKGROUND
We aimed to evaluate longitudinal changes in bone health over 4 years, examine differences based on diabetes duration, and identify predictors of skeletal outcomes in children and adolescents with T1DM.
METHODS
A single-centre, retrospective, longitudinal observational study was conducted at tertiary care...
Shruti A. Mondkar, Madhura Karuggipkar, Mugdha Deshpande et al.· Bone· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.